\-\ Texto\\:\\ \ \(0\)\
\-\ painless\\ palpable\\ testicular\\ mass\\ within\\ the\\ left\\ testicle\\.\ \(0\)\
\-\ afp\\ \\ 3\\.3\\ ng\\/ml\\ \\(normal\\)\ \(0\)\
\-\ hcg\\ quantitative\\ less\\ than\\ 0\\.1\\ miu\\/ml\\ \\(normal\\)\ \(0\)\
\-\ ldh\\ 505\\ u\\/l\\ \\(normal\\)\ \(0\)\
\-\ pathologic\\ specimen\\ status\\ post\\ orchiectomy\\ demonstrated\\ a\\ mixed\\ germ\\ cell\\ tumor\\ with\\ a\\ \\ predominant\\ embryonal\\ carcinoma\\ component\\ and\\ a\\ smaller\\ yolk\\ sac\\ tumor\\ component\\ involving\\ less\\ than\\ 5\\%\\ of\\ the\\ testicle\\.\ \(0\)\
\-\ orchiectomy\\ for\\ testicular\\ mass\\.\\ \\ based\\ on\\ the\\ type\\ of\\ tumor\\ and\\ staging\\,\\ chemotherapy\\,\\ retroperitoneal\\ lymph\\ node\\ dissection\\,\\ surveillance\\,\\ and\\ radiation\\ therapy\\ can\\ be\\ performed\\.\ \(0\)\
\-\ within\\ the\\ mid\\ to\\ upper\\ pole\\ of\\ the\\ left\\ testicle\\,\\ there\\ is\\ a\\ heteroechoic\\ well\\ defined\\ mass\\ with\\ a\\ smaller\\ internal\\ hyperechoic\\ focus\\ demonstrating\\ posterior\\ shadowing\\.\\ \\ the\\ mass\\ in\\ the\\ left\\ testicle\\ measures\\ 1\\.6\\ cm\\ x\\ 1\\.8\\ cm\\ x\\ 1\\.7\\ cm\\.\\ \\ normal\\ testicular\\ blood\\ flow\\ was\\ seen\\ around\\ and\\ within\\ the\\ mass\\ on\\ color\\ doppler\\.\\ \\ additionally\\,\\ small\\ hydroceles\\ were\\ seen\\ around\\ both\\ testicles\\.\ \(0\)\
\-\ mixed\\ germ\\ cell\\ tumor\\ of\\ the\\ testicle\ \(0\)\
\-\ \\(embryonal\\ and\\ yolk\\ sac\\ tumor\\ components\\)\ \(0\)\
\-\ teratoma\ \(130\)\
\-\ yolk\\ sac\\ tumor\ \(8\)\
\-\ choriocarcinoma\ \(11\)\
\-\ burned\\ out\\ germ\\ cell\\ tumor\ \(0\)\
\-\ sex\\ cord\\-stromal\\ tumors\\ \\(leydig\\ cell\\ tumor\\ or\\ sertoli\\ cell\\ tumor\\)\ \(0\)\
\-\ seminoma\ \(37\)\
\-\ metastatic\\ disease\\ \\(prostate\\,\\ kidney\\,\\ lymphoma\\,\\ leukemia\\)\ \(0\)\
\-\ hematoma\ \(500\)\
\-\ orchitis\ \(17\)\
\-\ abscess\ \(594\)\
\-\ infarction\\ \ \(73\)\
\-\ granuloma\ \(235\)\
\-\ the\\ patient\\ presented\\ with\\ a\\ painless\\ left\\ testicular\\ mass\\.\ \(0\)\
\-\ nonseminomatous\\ tumors\\ such\\ as\\ the\\ one\\ in\\ this\\ case\\ most\\ often\\ occur\\ among\\ men\\ in\\ their\\ thirties\\.\\ \\ this\\ patient\\ was\\ slightly\\ younger\\ than\\ the\\ average\\ age\\ for\\ nonseminomatous\\ tumors\\ since\\ he\\ was\\ only\\ 23\\ years\\ old\\.\\ \\ testicular\\ tumors\\ are\\ the\\ most\\ common\\ malignancy\\ in\\ the\\ age\\ group\\ of\\ 15\\-35\\ years\\.\ \(0\)\
\-\ embryonal\\ carcinomas\\ are\\ more\\ aggressive\\ than\\ seminomas\\.\\ \\ only\\ 3\\%\\ of\\ nonseminomatous\\ germ\\ cell\\ tumors\\ are\\ pure\\ embryonal\\ carcinomas\\.\\ \\ around\\ 45\\%\\ of\\ mixed\\ germ\\ cell\\ tumors\\ contain\\ embryonal\\ components\\.\\ \\ this\\ patient\\â\\€\\™s\\ mixed\\ germ\\ cell\\ tumor\\ had\\ mixed\\ histologic\\ characteristics\\ involving\\ yolk\\ sac\\ tumor\\ and\\ embryonal\\ carcinoma\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\â\\€\\™s\\ mixed\\ germ\\ cell\\ tumor\\ had\\ ultrasound\\ characteristics\\ which\\ are\\ typical\\ for\\ embryonal\\ carcinoma\\.\\ \\ embryonal\\ carcinomas\\ like\\ the\\ one\\ in\\ this\\ case\\ are\\ predominantly\\ hypoechoic\\ lesions\\ with\\ poorly\\ defined\\ margins\\ and\\ an\\ inhomogeneous\\ echotexture\\.\\ \\ this\\ tumor\\ also\\ had\\ echogenic\\ foci\\ within\\ it\\ which\\ often\\ represent\\ hemorrhage\\,\\ calcification\\,\\ or\\ fibrosis\\.\\ \\ the\\ mass\\ was\\ palpable\\ which\\ may\\ occur\\ with\\ embryonal\\ carcinomas\\ since\\ tumor\\ invasion\\ of\\ the\\ tunica\\ albuginea\\ is\\ common\\ and\\ may\\ distort\\ the\\ contour\\ of\\ the\\ testis\\.\\ \\ this\\ tumor\\ did\\ not\\ extend\\ beyond\\ the\\ tunica\\ vaginalis\\ though\\.\ \(0\)\
\-\ although\\ this\\ tumor\\ has\\ a\\ small\\ yolk\\ sac\\ tumor\\ component\\,\\ the\\ patient\\â\\€\\™s\\ afp\\ \\(alpha\\ fetoprotein\\)\\ level\\ was\\ not\\ elevated\\ or\\ abnormal\\.\\ \\ yolk\\ sac\\ tumors\\ are\\ frequently\\ seen\\ in\\ tumors\\ with\\ mixed\\ histologic\\ features\\ in\\ adults\\ and\\ indicate\\ a\\ poorer\\ prognosis\\.\\ \\ the\\ ultrasound\\ appearance\\ of\\ yolk\\ sac\\ tumors\\ is\\ consistent\\ with\\ the\\ inhomogeneous\\ appearance\\ and\\ echogenic\\ foci\\ seen\\ in\\ this\\ patient\\â\\€\\™s\\ tumor\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ dogra\\ vs\\,\\ gottlieb\\ rh\\,\\ oka\\ m\\,\\ rubens\\ dj\\.\\ \\ sonography\\ of\\ the\\ scrotum\\.\\ \\ radiology\\ 2003\\;\\ 227\\:\\ 18\\-36\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ embryonal\\:\\ 0\\.09874327733115527\ \(0\)\
\-\ yolk\\:\\ 0\\.07448003458876061\ \(0\)\
\-\ tumor\\:\\ 0\\.06817524986500875\ \(0\)\
\-\ germ\\:\\ 0\\.05883552259516808\ \(0\)\
\-\ sac\\:\\ 0\\.055130850050441334\ \(0\)\
\-\ tumors\\:\\ 0\\.05491910117687169\ \(0\)\
\-\ mixed\\:\\ 0\\.04994384740794053\ \(0\)\
\-\ testicle\\:\\ 0\\.04520033662946843\ \(0\)\
\-\ carcinomas\\:\\ 0\\.041698204667614404\ \(0\)\
\-\ testicular\\:\\ 0\\.04167967324261582\ \(0\)\
\-\ nonseminomatous\\:\\ 0\\.041099318506838775\ \(0\)\
\-\ cell\\:\\ 0\\.0394946129358049\ \(0\)\
\-\ inhomogeneous\\:\\ 0\\.02476400506073176\ \(0\)\
\-\ tunica\\:\\ 0\\.024401608939802765\ \(0\)\
\-\ component\\:\\ 0\\.022259677974698366\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.021130881695608426\ \(0\)\
\-\ histologic\\:\\ 0\\.020586772023970884\ \(0\)\
\-\ around\\:\\ 0\\.02029290714033489\ \(0\)\
\-\ afp\\:\\ 0\\.020000647766072563\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.019422256575250617\ \(0\)\
\-\ s\\:\\ 0\\.018637016479958836\ \(0\)\
\-\ than\\:\\ 0\\.017026987489872806\ \(0\)\
\-\ cord\\-stromal\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ rubens\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 18\\-36\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ this\\:\\ 0\\.016445313535793152\ \(0\)\
\-\ painless\\:\\ 0\\.016325968999686153\ \(0\)\
\-\ characteristics\\:\\ 0\\.016164145370717347\ \(0\)\
\-\ echogenic\\:\\ 0\\.016164145370717347\ \(0\)\
\-\ components\\:\\ 0\\.01593363350069288\ \(0\)\
\-\ mass\\:\\ 0\\.01581602100500561\ \(0\)\
\-\ smaller\\:\\ 0\\.01575167144298324\ \(0\)\
\-\ 505\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ heteroechoic\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ burned\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ thirties\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ 15\\-35\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ distort\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ dogra\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ gottlieb\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ oka\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ seminomas\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ vaginalis\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ 227\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ hydroceles\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ foci\\:\\ 0\\.013946859114650361\ \(0\)\
\-\ carcinoma\\:\\ 0\\.01381327568450114\ \(0\)\
\-\ pure\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ poorer\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ dj\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ defined\\:\\ 0\\.013690428389192063\ \(0\)\
\-\ are\\:\\ 0\\.013287534667638042\ \(0\)\
\-\ cm\\:\\ 0\\.013071993067397258\ \(0\)\
\-\ albuginea\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ fetoprotein\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ rh\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ seen\\:\\ 0\\.012841274639298024\ \(0\)\
\-\ leydig\\:\\ 0\\.012582307693213456\ \(0\)\
\-\ within\\:\\ 0\\.012396436565673625\ \(0\)\
\-\ sertoli\\:\\ 0\\.01238200253036588\ \(0\)\
\-\ occur\\:\\ 0\\.012190291364188359\ \(0\)\
\-\ since\\:\\ 0\\.011934466242198542\ \(0\)\
\-\ 0\\.1\\:\\ 0\\.011883211153051257\ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.011883211153051257\ \(0\)\
\-\ orchitis\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ palpable\\:\\ 0\\.011515669363497303\ \(0\)\
\-\ involving\\:\\ 0\\.011400788076058151\ \(0\)\
\-\ 3\\.3\\:\\ 0\\.01137320357397392\ \(0\)\
\-\ sex\\:\\ 0\\.01137320357397392\ \(0\)\
\-\ \\%\\:\\ 0\\.011368751140756698\ \(0\)\
\-\ quantitative\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ miu\\/ml\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ testicles\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ less\\:\\ 0\\.011003574160922746\ \(0\)\
\-\ alpha\\:\\ 0\\.010883034164654339\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.010798525110337165\ \(0\)\
\-\ x\\:\\ 0\\.010718883404363031\ \(0\)\
\-\ had\\:\\ 0\\.010516253721905181\ \(0\)\
\-\ predominant\\:\\ 0\\.01049369117483302\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.010424551166903601\ \(0\)\
\-\ often\\:\\ 0\\.01036681957612035\ \(0\)\
\-\ echotexture\\:\\ 0\\.010293386011985442\ \(0\)\
\-\ 1\\.7\\:\\ 0\\.010231047945782038\ \(0\)\
\-\ normal\\:\\ 0\\.010187166955126243\ \(0\)\
\-\ ldh\\:\\ 0\\.010170689203739109\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.010170689203739109\ \(0\)\
\-\ surveillance\\:\\ 0\\.010112187951520945\ \(0\)\
\-\ seminoma\\:\\ 0\\.010112187951520945\ \(0\)\
\-\ scrotum\\:\\ 0\\.010112187951520945\ \(0\)\
\-\ u\\/l\\:\\ 0\\.009894677778179227\ \(0\)\
\-\ testis\\:\\ 0\\.009894677778179227\ \(0\)\
\-\ age\\:\\ 0\\.00988939287279204\ \(0\)\
\-\ patient\\:\\ 0\\.009771010618818113\ \(0\)\
\-\ only\\:\\ 0\\.009769626077889488\ \(0\)\
\-\ specimen\\:\\ 0\\.00974646191987179\ \(0\)\
\-\ among\\:\\ 0\\.009653704953770208\ \(0\)\
\-\ sonography\\:\\ 0\\.009653704953770208\ \(0\)\
\-\ ultrasound\\:\\ 0\\.00963924937264754\ \(0\)\
\-\ \\(\\:\\ 0\\.009613178866363162\ \(0\)\
\-\ years\\:\\ 0\\.00954084842972807\ \(0\)\
\-\ \\)\\:\\ 0\\.009495748754359573\ \(0\)\
\-\ younger\\:\\ 0\\.00948075480509012\ \(0\)\
\-\ average\\:\\ 0\\.00948075480509012\ \(0\)\
\-\ beyond\\:\\ 0\\.009439868483377262\ \(0\)\
\-\ was\\:\\ 0\\.009394273024844932\ \(0\)\
\-\ staging\\:\\ 0\\.009360642824821049\ \(0\)\
\-\ appearance\\:\\ 0\\.009292420443857953\ \(0\)\
\-\ indicate\\:\\ 0\\.009211457244133796\ \(0\)\
\-\ men\\:\\ 0\\.009175920869585977\ \(0\)\
\-\ hcg\\:\\ 0\\.009141036575539975\ \(0\)\
\-\ which\\:\\ 0\\.009097782816972712\ \(0\)\
\-\ contain\\:\\ 0\\.0089756157067384\ \(0\)\
\-\ one\\:\\ 0\\.008805062293956821\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.008655586591112515\ \(0\)\
\-\ shadowing\\:\\ 0\\.008628996777472324\ \(0\)\
\-\ prostate\\:\\ 0\\.008628996777472324\ \(0\)\
\-\ common\\:\\ 0\\.008502917155727745\ \(0\)\
\-\ group\\:\\ 0\\.008452605649238549\ \(0\)\
\-\ m\\:\\ 0\\.008381747484224801\ \(0\)\
\-\ leukemia\\:\\ 0\\.008335934648523164\ \(0\)\
\-\ adults\\:\\ 0\\.008291199862572225\ \(0\)\
\-\ 2003\\:\\ 0\\.008162984499843077\ \(0\)\
\-\ extend\\:\\ 0\\.0081424314274016\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.008122098178130218\ \(0\)\
\-\ dissection\\:\\ 0\\.007985547351949123\ \(0\)\
\-\ granuloma\\:\\ 0\\.007985547351949123\ \(0\)\
\-\ aggressive\\:\\ 0\\.007948268889233579\ \(0\)\
\-\ color\\:\\ 0\\.007929900237310125\ \(0\)\
\-\ poorly\\:\\ 0\\.007929900237310125\ \(0\)\
\-\ contour\\:\\ 0\\.00787583572149162\ \(0\)\
\-\ doppler\\:\\ 0\\.007858150564338933\ \(0\)\
\-\ invasion\\:\\ 0\\.007823266270292931\ \(0\)\
\-\ 23\\:\\ 0\\.007722297020646642\ \(0\)\
\-\ \\,\\:\\ 0\\.0077198687885158\ \(0\)\
\-\ prognosis\\:\\ 0\\.007705978116290384\ \(0\)\
\-\ predominantly\\:\\ 0\\.007610901271091408\ \(0\)\
\-\ teratoma\\:\\ 0\\.007595507335287949\ \(0\)\
\-\ pole\\:\\ 0\\.007565088435389772\ \(0\)\
\-\ though\\:\\ 0\\.007535148593245021\ \(0\)\
\-\ like\\:\\ 0\\.007520353649438832\ \(0\)\
\-\ 45\\:\\ 0\\.007505672953442805\ \(0\)\
\-\ most\\:\\ 0\\.007501274303148578\ \(0\)\
\-\ small\\:\\ 0\\.007485077126924406\ \(0\)\
\-\ node\\:\\ 0\\.007433923280471613\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.007405964825358124\ \(0\)\
\-\ margins\\:\\ 0\\.007378411579535753\ \(0\)\
\-\ focus\\:\\ 0\\.007298069736779322\ \(0\)\
\-\ left\\:\\ 0\\.007270762503976538\ \(0\)\
\-\ fibrosis\\:\\ 0\\.0072336181176240345\ \(0\)\
\-\ represent\\:\\ 0\\.0071348353439915045\ \(0\)\
\-\ may\\:\\ 0\\.007126723836114539\ \(0\)\
\-\ pathologic\\:\\ 0\\.007110921309377702\ \(0\)\
\-\ their\\:\\ 0\\.007110921309377702\ \(0\)\
\-\ case\\:\\ 0\\.007108381874020041\ \(0\)\
\-\ demonstrating\\:\\ 0\\.0070524200571595395\ \(0\)\
\-\ additionally\\:\\ 0\\.007040932767319306\ \(0\)\
\-\ frequently\\:\\ 0\\.007040932767319306\ \(0\)\
\-\ measures\\:\\ 0\\.0069514508075132495\ \(0\)\
\-\ radiology\\:\\ 0\\.006865991895227572\ \(0\)\
\-\ features\\:\\ 0\\.0068555746599336075\ \(0\)\
\-\ mid\\:\\ 0\\.00679424222225638\ \(0\)\
\-\ references\\:\\ 0\\.006754426302398503\ \(0\)\
\-\ infarction\\:\\ 0\\.006639749895110437\ \(0\)\
\-\ slightly\\:\\ 0\\.006566970072732077\ \(0\)\
\-\ lymph\\:\\ 0\\.006558065416244575\ \(0\)\
\-\ typical\\:\\ 0\\.006514157213212923\ \(0\)\
\-\ in\\:\\ 0\\.00640908334814076\ \(0\)\
\-\ vs\\:\\ 0\\.006396349753613684\ \(0\)\
\-\ the\\:\\ 0\\.006307952153777603\ \(0\)\
\-\ malignancy\\:\\ 0\\.006277737030040905\ \(0\)\
\-\ based\\:\\ 0\\.006195228825602587\ \(0\)\
\-\ a\\:\\ 0\\.006031936149332339\ \(0\)\
\-\ calcification\\:\\ 0\\.005896930833568686\ \(0\)\
\-\ did\\:\\ 0\\.0058658149068306535\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0058230908462754095\ \(0\)\
\-\ status\\:\\ 0\\.0057991013710677825\ \(0\)\
\-\ hematoma\\:\\ 0\\.005781305852513479\ \(0\)\
\-\ kidney\\:\\ 0\\.005723162462072262\ \(0\)\
\-\ or\\:\\ 0\\.005712106933253085\ \(0\)\
\-\ elevated\\:\\ 0\\.005512008291557154\ \(0\)\
\-\ although\\:\\ 0\\.005486557567636129\ \(0\)\
\-\ type\\:\\ 0\\.005476471917009335\ \(0\)\
\-\ internal\\:\\ 0\\.005446532074864585\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.005407331909079916\ \(0\)\
\-\ flow\\:\\ 0\\.005368923720263339\ \(0\)\
\-\ out\\:\\ 0\\.005368923720263339\ \(0\)\
\-\ radiation\\:\\ 0\\.00533127613985235\ \(0\)\
\-\ abscess\\:\\ 0\\.005136570806338911\ \(0\)\
\-\ post\\:\\ 0\\.005115655956411205\ \(0\)\
\-\ such\\:\\ 0\\.0050785794483666396\ \(0\)\
\-\ 1\\.\\:\\ 0\\.005074504118436503\ \(0\)\
\-\ demonstrated\\:\\ 0\\.00476695814155317\ \(0\)\
\-\ 5\\:\\ 0\\.0047531566966619076\ \(0\)\
\-\ not\\:\\ 0\\.004695128029437017\ \(0\)\
\-\ level\\:\\ 0\\.004682298531648159\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0046429631832499724\ \(0\)\
\-\ abnormal\\:\\ 0\\.004633255209724166\ \(0\)\
\-\ he\\:\\ 0\\.0045326755551958545\ \(0\)\
\-\ performed\\:\\ 0\\.004529616599291481\ \(0\)\
\-\ blood\\:\\ 0\\.004434241582717299\ \(0\)\
\-\ presented\\:\\ 0\\.004428436568483668\ \(0\)\
\-\ lesions\\:\\ 0\\.0043489743466614975\ \(0\)\
\-\ therapy\\:\\ 0\\.004343423566997363\ \(0\)\
\-\ \\:\\:\\ 0\\.004297622874489221\ \(0\)\
\-\ for\\:\\ 0\\.004158411494159972\ \(0\)\
\-\ both\\:\\ 0\\.004148669183813919\ \(0\)\
\-\ metastatic\\:\\ 0\\.004089561603832871\ \(0\)\
\-\ more\\:\\ 0\\.004063072831391951\ \(0\)\
\-\ consistent\\:\\ 0\\.003983456784850196\ \(0\)\
\-\ upper\\:\\ 0\\.003920305143286537\ \(0\)\
\-\ \\;\\:\\ 0\\.0038506106244345886\ \(0\)\
\-\ 3\\:\\ 0\\.0038041359823318245\ \(0\)\
\-\ posterior\\:\\ 0\\.0037445599785217655\ \(0\)\
\-\ were\\:\\ 0\\.0036887572940873027\ \(0\)\
\-\ can\\:\\ 0\\.00368483336971306\ \(0\)\
\-\ well\\:\\ 0\\.003675058845948006\ \(0\)\
\-\ it\\:\\ 0\\.0036518030124201837\ \(0\)\
\-\ and\\:\\ 0\\.0034222244435782975\ \(0\)\
\-\ is\\:\\ 0\\.0032069816257683974\ \(0\)\
\-\ also\\:\\ 0\\.0032026988472816566\ \(0\)\
\-\ has\\:\\ 0\\.0030507604001792357\ \(0\)\
\-\ on\\:\\ 0\\.0027524373093742514\ \(0\)\
\-\ disease\\:\\ 0\\.0026553945650488672\ \(0\)\
\-\ be\\:\\ 0\\.0025052409189048083\ \(0\)\
\-\ as\\:\\ 0\\.0024573716842093683\ \(0\)\
\-\ of\\:\\ 0\\.0024363912714408225\ \(0\)\
\-\ there\\:\\ 0\\.0024177101833935148\ \(0\)\
\-\ an\\:\\ 0\\.002246511148830285\ \(0\)\
\-\ \\.\\:\\ 0\\.0018222195335139723\ \(0\)\
\-\ old\\:\\ 0\\.0016633737582932597\ \(0\)\
\-\ with\\:\\ 0\\.0015570897958730573\ \(0\)\
\-\ to\\:\\ 0\\.0008119165559752591\ \(0\)\
